Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Medicines Co/The

+ Add to Watchlist

MDCO:US

27.6300 USD 0.5200 1.92%

As of 20:10:00 ET on 05/27/2015.

Snapshot for Medicines Co/The (MDCO)

Open: 27.0800 Day's Range: 26.8100 - 27.7100 Volume: 671,499
Previous Close: 27.1100 52wk Range: 19.9200 - 32.4400 1-Yr Rtn: +0.73%

Stock Chart for MDCO

No chart data available.
  • MDCO:US 27.6300
  • 1D
  • 1M
  • 1Y
27.1100
Interactive MDCO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MDCO

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 150.9836
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4284
Est. EPS (USD) (12/2015) 0.1830
Est. PEG Ratio 1.0137
Market Cap (M USD) 1,829.93
Shares Outstanding (M) 66.23
30 Day Average Volume 887,005
Price/Book (mrq) 1.8257
Price/Sale (ttm) 2.6532
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MDCO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MDCO

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

Clive A MeanwellChairman/CEOGlenn P SblendorioPresident/CFO/Treasurer
William B O'ConnorSenior VP/Chief Acctg OfficerStephen M RodinSenior VP/Secy/General Counsel
More Company Profile & Key Executives for MDCO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil